Full Text View
Tabular View
Study Results
Related Studies
Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment
This study has been completed.
Study NCT00749463   Information provided by Johnson & Johnson Consumer and Personal Products Worldwide

First Received on September 8, 2008.   Last Updated on July 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tobacco Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Nicotine Gum
Nicotine Patch
Additional drug interventions recognized in this trial
Nicotine
Nicotine polacrilex
More general drug interventions related to this trial
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
McNeil AB


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services